SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

META is trending as investors grapple with the implications of increased AI spending and a one-time tax charge impacting earnings, leading to community debates on whether the dip is a buying opportunity or a sign of deeper concerns. Community members are actively discussing potential support levels, options activity, and whether the stock is oversold, while others express frustration with the stock's recent performance. Despite the concerns, some bulls remain confident in META's long-term potential and ability to monetize its massive user base.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

AUPH is trending as the community discusses a recent event involving an FDA official's social media post and its impact on the stock. Traders are evaluating the situation, with some speculating about a potential buying opportunity, while others express concerns about the company's response and the need for accountability. Investors are closely watching for further developments and any potential impact on the company's prospects, particularly regarding upcoming earnings and AUR200.

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

GALT is trending as investors anticipate upcoming presentations at the AASLD Liver Meeting in November, with the community closely watching for potential partnership or buyout news before year-end. Discussions center on the value of Belapectin, especially in combination with GLP-1 drugs, and the possibility of a short squeeze given the high short interest. Community members are actively debating potential buyout prices and the impact of upcoming presentations on the stock's valuation.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is trending as investors discuss its potential role in powering AI data centers with its natural gas fuel cell technology, drawing comparisons to Bloom Energy's success in the sector. Community members are closely watching for news of new contracts and partnerships, anticipating a significant impact on the stock's valuation given its smaller market cap compared to its peers. Some believe that the company is undervalued and that a squeeze is coming.

Lumen Technologies, Inc. is an investment holding company, which engages in the provision of integrated communications to residential and business customers. It operates through the Business and Mass Markets segments. The Business segment provides products and services under four sales channels to enterprise and commercial customers. The Mass Markets segment focuses on consumer and small business customers. The company was founded in 1930 and is headquartered in Monroe, LA.

Lumen Technologies Inc

LUMN is trending as investors rally behind the company's AI-driven turnaround story following a narrowed Q3 loss and new AI-driven connectivity deals. The community is actively discussing the potential for a significant bounce, with some anticipating a short squeeze and a run to higher price levels. Bullish sentiment is fueled by the improving outlook and strategic partnerships, positioning LUMN as a key player in the AI infrastructure space.

Ucore Rare Metals, Inc. Is a technology company, which engages in the business of metal separation products, and services to the mining and mineral extraction industry. Its projects include Bokan-Dotson Ridge Rare Earth Element. The company was founded on October 5, 2006 and is headquartered in Halifax, Canada.

Ucore Rare Metals Inc

Ucore Rare Metals Inc.

Ucore Rare Metals is trending amid speculation of upcoming deals with the Canadian government, potentially mirroring recent offtake agreements in the critical minerals sector. Community members are excited about Ucore's refining capabilities and its role in establishing North American supply chain independence, especially with the G7 summit underway. Trading halts and price volatility reflect both anticipation and nervousness as investors await news.

"Shina Inu is a decentralized meme token on the Ethereum blockchain. Its mission is to give back to the crypto community, give to charity, and win the heart of the greatest token of all time, Shiba Inu!   Shina Token is a very fun meme token project that has sold many rare and beautiful NFTs. NFT sales are used to support the team and provide upcoming features such as exclusive access to events and rewards that will soon be announced."

Shina Inu

Shina Inu is trending as community members highlight ongoing accumulation and bullish technical setups, suggesting a big move is imminent. Discussions center on the anticipation of a catalyst (CBM) and the belief that the market is underestimating its potential. The focus remains on patience and conviction, with holders believing that silent accumulation will lead to substantial gains.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

ARDX is trending as investors discuss TD Cowen's recent price target increase and the company's raised full-year revenue projection for its IBS treatment. Community members are actively debating valuation, consolidation patterns, and potential catalysts, with some noting strong consolidation and support at the $6 level. The conversation highlights both optimism and caution around the stock's near-term direction.

Solid Power, Inc. engages in the manufacture and supply of power batteries. The firm develops all solid state battery cell technology that replaces the liquid or gel polymer electrolyte used in conventional lithium-ion battery cells with a sulfide-based solid electrolyte. It focuses on the development and commercialization of all solid state battery cells and solid electrolyte materials, primarily for the battery-powered electric vehicle market. The company was founded on August 3, 2011 and is headquartered in Louisville, CO.

Solid Power Inc

SLDP is trending following news of a collaboration with Samsung SDI and BMW to advance solid-state battery technology, with community members expressing excitement about the potential for disruption in the EV battery space and beyond. Some are calling the Samsung partnership a "huge" catalyst, while others debate the timeline for mass production and compare SLDP's technology and partnerships to competitors. Discussions also highlight the company's potential beyond EVs, including applications in phones and robotics.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as investors discuss its potential trigger points and market control, with some expressing excitement about options and long-term prospects. The community is highlighting QNX integration with NVIDIA chips and government support for Canadian businesses, while also pondering potential drivers for recent market activity and keeping an eye on upcoming announcements.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$BBBY I root for turning around a company, but In my personal opinion I don’t see how you could value this stock anymore than 5$ in the short term.

KendallRoyWayStarRoyCo

Adam Murrow

PlanetDruidia

StockTwits for iOS

Bed Bath & Beyond Inc

 I root for turning around a company, but In my personal opinion I don’t see how you could value this stock anymore than 5$ in the short term.

Christian

@BigClaps that’s about as dumb a comment as I have read today. I hate almost everything about this company, including its leadership. But they have over $3/share in cash alone. They are about to be profitable, and they are going to get a windfall in the near future when Tzero goes public. 

You can say negative things, but saying dumb things isn’t allowed here. Sorry.

Steve Punt

Syed Salman Maqsood

 that’s about as dumb a comment as I have read today. I hate almost everything about this company, including its leadership. But they have over $3/share in cash alone. They are about to be profitable, and they are going to get a windfall in the near future when Tzero goes public. 

You can say negative things, but saying dumb things isn’t allowed here. Sorry.

@BigClaps dude you sound extremely stupid do some research first before you comment

 dude you sound extremely stupid do some research first before you comment

@ShowMeDemGains how is that dumb to say? I’m not even being a hater..

 how is that dumb to say? I’m not even being a hater..

@BigClaps did you read what I wrote? I very clearly explained why it’s dumb.

 did you read what I wrote? I very clearly explained why it’s dumb.

@ShowMeDemGains having 3$ a share of cash on hand and -17% yoy return does not justify a double digit eval in the short term like I said in my opinion. Like I said I root for company turn arounds but I just don’t see the bull case in the short term until the ship is completely turned around

 having 3$ a share of cash on hand and -17% yoy return does not justify a double digit eval in the short term like I said in my opinion. Like I said I root for company turn arounds but I just don’t see the bull case in the short term until the ship is completely turned around

@BigClaps what do you value their Tzero and grainchain investments at? You’re saying the enterprise value is no more than $100M, so what value do you equate to the retail operation that appears to be in a break even Q this current Q and headed into profitability the following, and then what do you value the MVI portfolio at (plus the direct Tzero and GC investments)?

 what do you value their Tzero and grainchain investments at? You’re saying the enterprise value is no more than $100M, so what value do you equate to the retail operation that appears to be in a break even Q this current Q and headed into profitability the following, and then what do you value the MVI portfolio at (plus the direct Tzero and GC investments)?

@ShowMeDemGains damn chat GPT even agrees with me

@BigClaps haha. Why didn’t you show us the commentary you provided to it?

Also, why can’t you answer my question about the value you prescribe to MVI (plus the direct Tzero and grainchain investments) and the retail biz?

 haha. Why didn’t you show us the commentary you provided to it?

Also, why can’t you answer my question about the value you prescribe to MVI (plus the direct Tzero and grainchain investments) and the retail biz?

@ShowMeDemGains Given the credible data point of 428 million shares as of March 2023, and later 782 million in October 2023, the shares outstanding are most likely in the hundreds of millions, not tens of millions.
Thus for valuation purposes it is safer to assume ~400 m-800 m shares outstanding rather than the lower earlier‐year counts.

If you assume, say, 450 million shares outstanding, then the book‐value / net‐asset floor calculation (net assets ~$131 M) results in ≈ $0.29/share (131 M / 450 M) as a rough asset‐floor. If you assume 750 million shares, then ~$0.17/share.
This reinforces that any “fair value” per share is very low given the high share count.

Therefore, a fair MVI range is ~1.0 ± 0.5×, which corresponds to:
 • Fair value per share ≈ $1–3 (low share count),
 • or $0.07–0.20 (high share count) if dilution is extreme.

So yes 5$ based off this data is a fair short term price like I explained. What am I saying that is so bad.. and how does that make me dumb?

$BBBY pray for humanity. This guy thinks there are hundreds of millions of shares outstanding. A year ago there were 45M and as of today’s filing there are 60M. 🤦‍♂️

 Given the credible data point of 428 million shares as of March 2023, and later 782 million in October 2023, the shares outstanding are most likely in the hundreds of millions, not tens of millions.
Thus for valuation purposes it is safer to assume ~400 m-800 m shares outstanding rather than the lower earlier‐year counts.

If you assume, say, 450 million shares outstanding, then the book‐value / net‐asset floor calculation (net assets ~$131 M) results in ≈ $0.29/share (131 M / 450 M) as a rough asset‐floor. If you assume 750 million shares, then ~$0.17/share.
This reinforces that any “fair value” per share is very low given the high share count.

Therefore, a fair MVI range is ~1.0 ± 0.5×, which corresponds to:
 • Fair value per share ≈ $1–3 (low share count),
 • or $0.07–0.20 (high share count) if dilution is extreme.

So yes 5$ based off this data is a fair short term price like I explained. What am I saying that is so bad.. and how does that make me dumb?

@BigClaps OMG. Please tell me you’re not this dumb. There are 60M shares outstanding. Go read the filing from today.

 OMG. Please tell me you’re not this dumb. There are 60M shares outstanding. Go read the filing from today.